AUA2014 Registration and Late Breaking Abstract Submission Site Now Open
Join us May 16 – 21, 2014 in Orlando, FL for AUA2014! This year's program begins on Friday, May 16 with a full day of programming, including the Urologic Oncology Symposium: Progress in Translational Urologic Oncology Research; the Basic Science Symposium: New Perspectives in Pelvic Health; Crossfire: Controversies in Urology, featuring debates on today's hottest topics in urology—plus, poster and podium sessions, courses, and more! Register today!
Research Activities at AUA2014
AUA's Annual Meeting 2014 features a non-stop program devoted exclusively to urologic research from Friday May 16 to Sunday May 17.
Friday, May 16, 2014
8 a.m. – 12:45 p.m. National Urology Residents Preceptorship Program (NURPP)
8 a.m. – 5 p.m. Urologic Oncology Research "Symposium Progress in Translational Urologic Oncology Research"
1 – 5 p.m. Basic Sciences Symposium "New Perspectives in Pelvic Health"
Saturday, May 17, 2014
8 – 11:30 a.m. Joint Meeting of the SUO and SBUR: New Landscape on Multidisciplinary Therapy for Hormone Refractory Advanced Prostate Cancer
8 a.m. – Noon "The Science of Female Pelvic Health"
1 – 3 p.m. Outstanding Poster Session on Research
2 – 4 p.m. Innovations in Urology
Sunday, May 18, 2014
8 a.m. – 5 p.m. AUA/NCI Joint Meeting "Specialized Programs of Research Excellence (SPORE) Workshop"
1 – 5:30 p.m. AUA Research Forum: "Showcasing Early Career Investigators"
1 – 3 p.m. Session I: Research Grantwriting Workshop
3 – 5:30 p.m. Session II: Early Career Investigator Research Showcase
TCGA Bladder Cancer Study Reveals Potential Drug Targets
Investigators with The Cancer Genome Atlas (TCGA) Research Network have identified new potential therapeutic targets for a major form of bladder cancer, including important genes and pathways that are disrupted in the disease. They also discovered that, at the molecular level, some subtypes of bladder cancer – also known as urothelial carcinoma – resemble subtypes of breast, head and neck, and lung cancers suggesting similar routes of development. Read the full paper here.
Seth Lerner, MD, professor and chair of urologic oncology at Baylor College of Medicine in Houston, was one of the senior authors of the paper. Dr. Lerner is a previous AUA Research Scholar (1990-1991) and recently served on the 2014 Research Scholars Program Research Grants Review Committee.
George M. O’Brien Urology Cooperative Research Centers Program (U54)
The National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) is pleased to announce the release of a new funding announcement titled “George M. O’Brien Urology Cooperative Research Centers Program (U54).” The application due date is March 18, 2014. Please be advised that, although not required, a letter of intent is strongly encouraged to be received by KUH by February 18, 2014. The RFA is available at http://grants.nih.gov/grants/guide/rfa-files/RFA-DK-13-020.html. To request additional information, please contact Dr. Deborah Hoshizaki at email@example.com.
SIU 2014 Abstract Submission Site Now Open
Abstracts can be submitted for the 34th Congress of the SIU in Glasgow, Scotland as moderated ePosters, unmoderated ePosters, unmoderated video presentations or for the SIU Residents' Forum. The deadline for submissions is April 1, 2014 at 11:59 p.m. EST.
National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) Funding Announcement: Fibrosis
The National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) is pleased to announce the release of a new funding announcement titled “Novel Methods for Detection and Measurement of Organ Fibrosis in Kidney, Bone Marrow, and Urological Diseases (U01).” The purpose of this FOA is to establish a consortium to carry out research on novel methods for detection and measurement of organ fibrosis after acute or chronic injury in kidney, bone marrow, prostate, or urinary tract. The application due date is March 19, 2014. Please be advised that, although not required, a letter of intent is strongly encouraged to be received by KUH by February 19, 2014. Access the RFA.
NIH CSR Early Career Reviewer Program
The NIH Center for Scientific Review (CSR) Early Career Reviewer (ECR) program was developed to train qualified scientists without prior CSR review experience to become effective reviewers, help emerging researchers advance their careers by exposing them to peer review, and enrich the existing pool of NIH reviewers by including scientists from less research-intensive institutions as well as those from traditionally research-intensive institutions.
Applicants should be full-time faculty members or researchers in a similar role, show evidence of an active independent program of research, have recent senior authored research publications in peer-reviewed journals, and have not served on a CSR study section in a role other than a mail reviewer or ARRA reviewer. Prior NIH funding is not a requirement.
Further information regarding the program may be found here.
Howard and Georgeanna Jones Foundation Grant Opportunities
The Howard and Georgeanna Jones Foundation for Reproductive Medicine, which supports scientific and medical research in the field of reproductive medicine has announced two new grant opportunities: the Young Investigator Achievement Awards and the Research Grant in Reproductive Medicine.
The two Young Investigator Achievement Awards available are designed to foster the career development of young research investigators working in an approved reproductive medicine fellowship program or young research investigators in the field of reproductive medicine. The proposed research must be focused on new discoveries in basic and clinical sciences and have current or potential impact on the understanding and treatment of infertility. Preference will be given to investigations that target improvement in the efficiency of in vitro fertilization. Grants will be in the amount of $60,000 for a period of one year.
The foundation will also award one Research Grant in Reproductive Medicine to fund an innovative research project designed to identify human fertilized eggs that have pregnancy potential. Funds may be used for support of a new or ongoing research/clinical investigation project, and the candidate must spend at least 80 percent of his or her time in research. The grant provides $100,000 for a period of one year. A second year of funding may be awarded upon review of a progress report and re-application.
Information regarding the programs and funding announcements may be found here. The application deadline is February 28, 2014.
BCAN Young Investigator Awards
The application process is now open for the Bladder Cancer Advocacy Network's (BCAN) Young Investigator Awards. The goal of these grants is to support the development of outstanding research scientists and clinical cancer research investigators who have demonstrated a commitment to improving the understanding and treatment of bladder cancer. These grants fund researchers who work in basic, translational, clinical, epidemiologic, bioengineering or any other scientific or research field, but are also working in a research environment capable of supporting transformational bladder cancer research. Applications are open to researchers and clinicians across the United States and Canada.
The deadline is March 5, 2014 to apply for one of these three research awards of $100,000 each, over a two-year period. More information on BCAN's Young Investigator Awards including the application and guidelines may be found here.